S.A. Bulgakov
ESSENTIAL PHOSPHOLIPIDS IN THE TREATMENT OF HEPATIC DISORDERS
|
№s3 / 2018
|
D.B. Tsurtsumiya, A.B. Karaya, P.V. Seliverstov, L.S. Oreshko, S.I. Sitkin, V.G. Radchenko
ALGORITHM OF TREATMENT OF NON-ALCOHOLIC FAT LIVER DISEASE
|
№13 / 2017
|
A.N. Kazyulin
POTENTIALS FOR THE EARLY PROPHYLAXIS OF PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN THE PRACTICE OF CLINICISTS
|
№2 / 2017
|
E.B. Grishchenko, M.I. Shchekina
THE ROLE OF HEPATOPROTECTORS IN THERAPY OF LIVER DISEASES
|
№14 / 2014
|
I.V. Maev, A.N. Kazyulin, S.M. Babina
THE USE OF USING DRUGS MADE BY NEW TECHNOLOGIES IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
|
№14 / 2014
|
T.R. Kameneva, M.V. Zhuravleva, O.A. Rogacheva
CURRENT ISSUES OF RATIONAL PHARMACOTHERAPY OF COMORBID CONDITIONS
|
№14 / 2013
|
S. M. Alekhin, M. N. Somova
NONALCOHOLIC FATTY LIVER DISEASE: NEW POTENTIALS FOR THE COMBINED THERAPY
|
№10 / 2013
|
A.A. Vizel, I.Yu.Vizel
Sarcoidosis: In Search For Best Therapy
|
№11 / 2012
|
L.A. Zvenigorodskaya, E.A. Cherkashova, N.G. Samsonova
Hepatoprotectors In The Treatment Of Nonalcoholic Fatty Liver Disease
|
№15 / 2011
|
I.V. Mayev, V.V. Tsukanov, Ye.V.Lukicheva, A.A. Samsonov, A.V. Vasyutin, I.N. Nikushkina
Prevalence, Pathogenesis And Principles Of Treatment Nonalcoholic Fatty Liver Disease
|
№12 / 2011
|
I.V. Mayev, V.V. Tsukanov, A.A. Samsonov, Yu.L. Tonkikh, A.V. Vasyutin, Yu.A. Kucheryavy
Pathogenesis And Principles Of Treatment Of Alcoholic Liver Disease
|
№11 / 2011
|
L.A. Zvenigorodskaya
Lipid-lowering Therapy In Patients With Nonalcoholic Fatty Liver Disease
|
№10 / 2011
|